Matthew P Pando

Title: The Innovative Contributions of Matthew P Pando

Introduction

Matthew P Pando is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target phosphodiesterase 10 (PDE 10A). With a total of five patents to his name, Pando's work has implications for treating various central nervous system diseases and metabolic disorders.

Latest Patents

Pando's latest patents include the invention of substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A). These compounds are designed to be useful in treating central nervous system diseases such as psychosis. Additionally, they have potential applications in addressing obesity, type II diabetes, metabolic syndrome, glucose intolerance, pain, and ophthalmic diseases. Another patent focuses on substituted 6,7-dialkoxy-3-isoquinolinol derivatives, which share similar therapeutic uses.

Career Highlights

Throughout his career, Matthew P Pando has worked with prominent companies in the pharmaceutical industry. He has been associated with Exonhit Therapeutics and Allergan, Inc., where he contributed to innovative research and development efforts. His work has been instrumental in advancing therapeutic options for patients with complex health conditions.

Collaborations

Pando has collaborated with esteemed colleagues, including Bertrand Leblond and Thierry Taverne. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical field.

Conclusion

Matthew P Pando's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in treating various health conditions.